[go: up one dir, main page]

GB202016934D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB202016934D0
GB202016934D0 GBGB2016934.8A GB202016934A GB202016934D0 GB 202016934 D0 GB202016934 D0 GB 202016934D0 GB 202016934 A GB202016934 A GB 202016934A GB 202016934 D0 GB202016934 D0 GB 202016934D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2016934.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
C4X Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C4X Discovery Ltd filed Critical C4X Discovery Ltd
Priority to GBGB2016934.8A priority Critical patent/GB202016934D0/en
Publication of GB202016934D0 publication Critical patent/GB202016934D0/en
Priority to PCT/EP2021/063934 priority patent/WO2021239743A1/en
Priority to JP2022572523A priority patent/JP7709466B2/en
Priority to KR1020227045479A priority patent/KR20230016220A/en
Priority to CA3180084A priority patent/CA3180084A1/en
Priority to IL298487A priority patent/IL298487A/en
Priority to EP21728073.4A priority patent/EP4157827A1/en
Priority to PH1/2022/500021A priority patent/PH12022500021A1/en
Priority to AU2021281378A priority patent/AU2021281378A1/en
Priority to MX2022014925A priority patent/MX2022014925A/en
Priority to BR112022024045A priority patent/BR112022024045A2/en
Priority to US17/926,864 priority patent/US20230227427A1/en
Priority to CONC2022/0018636A priority patent/CO2022018636A2/en
Ceased legal-status Critical Current

Links

GBGB2016934.8A 2010-10-26 2020-10-26 Therapeutic compounds Ceased GB202016934D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB2016934.8A GB202016934D0 (en) 2020-10-26 2020-10-26 Therapeutic compounds
US17/926,864 US20230227427A1 (en) 2010-10-26 2021-05-25 Il-17a modulators
EP21728073.4A EP4157827A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
JP2022572523A JP7709466B2 (en) 2020-05-27 2021-05-25 IL-17A Modulators
KR1020227045479A KR20230016220A (en) 2020-05-27 2021-05-25 IL-17A modulator
CA3180084A CA3180084A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
IL298487A IL298487A (en) 2020-05-27 2021-05-25 Il-17a modulators
PCT/EP2021/063934 WO2021239743A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
PH1/2022/500021A PH12022500021A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
AU2021281378A AU2021281378A1 (en) 2020-05-27 2021-05-25 IL-17A modulators
MX2022014925A MX2022014925A (en) 2020-05-27 2021-05-25 IL-17A MODULATORS.
BR112022024045A BR112022024045A2 (en) 2020-05-27 2021-05-25 IL-17A MODULATORS
CONC2022/0018636A CO2022018636A2 (en) 2020-05-27 2022-12-22 il-17a modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2016934.8A GB202016934D0 (en) 2020-10-26 2020-10-26 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB202016934D0 true GB202016934D0 (en) 2020-12-09

Family

ID=73726909

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2016934.8A Ceased GB202016934D0 (en) 2010-10-26 2020-10-26 Therapeutic compounds

Country Status (1)

Country Link
GB (1) GB202016934D0 (en)

Similar Documents

Publication Publication Date Title
GB202005852D0 (en) Therapeutic compounds
GB202005863D0 (en) Therapeutic compounds
GB202006960D0 (en) Therapeutic
GB202001980D0 (en) Therapeutic mentods
GB201908885D0 (en) Therapeutic compounds
GB202103640D0 (en) Therapeutic compounds
GB202103164D0 (en) Therapy
GB202002639D0 (en) Therapy
GB202103642D0 (en) Therapeutic compounds
GB202111035D0 (en) Therapy
GB202108303D0 (en) Therapy
GB202110728D0 (en) Therapeutic compounds
GB202101574D0 (en) Therapeutic compounds
GB202101577D0 (en) Therapeutic compounds
GB202016934D0 (en) Therapeutic compounds
GB202016931D0 (en) Therapeutic compounds
GB202012670D0 (en) Therapeutic compounds
GB202007925D0 (en) Therapeutic compounds
GB202007931D0 (en) Therapeutic compounds
GB202005846D0 (en) Therapeutic compounds
GB202005848D0 (en) Therapeutic compounds
IL321362A (en) Therapeutic compounds
GB202302445D0 (en) Therapeutic compounds
GB202217955D0 (en) Therapeutic compounds
GB202207050D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: SANOFI

Free format text: FORMER OWNER: C4X DISCOVERY LIMITED

AT Applications terminated before publication under section 16(1)